Diabetes stocks are surprise winners from Novo Nordisk’s Wegovy study, analysts say
DaVita 3Q Rev $3.1B >DVA
Who is having the most influence over your money in 2023? Meet the MarketWatch 50.
DaVita plays down Ozempic’s potential in treating kidney disease
U.S. stocks score fourth day of gains after Fed minutes, wholesale inflation data
Exxon, Pioneer Natural, Silk Road Medical, DaVita, Amgen, Lilly, and More Stock Market Movers
Dialysis-company stocks slide after Ozempic trial's success in treating kidney disease
Dialysis Providers Are the Top Decliners in the S&P 500 Wednesday
Novo Nordisk Halts Ozempic Kidney Trial. Why It's Bad for DaVita.
Stock Market News
DaVita Stock Sees Rising Relative Strength
Novavax and Palantir rocket higher, while PayPal slumps and other stocks on the move
DaVita Is the S&P 500’s Top Gainer. Here’s Why the Dialysis Stock Is Surging.
DaVita Is the S&P 500's Top Gainer. Why the Dialysis Stock Is Surging.
Stock Market News
DaVita 1Q Rev $2.87B >DVA
Aerospace Executives Go to Trial Over Alleged No-Poach Deals
Junk Bonds Rally on Hopes Inflation Has Peaked
Unprofitable public companies gambled more than $200 million in California, and lost big
Dialysis company DaVita stock suffered worst day in 22 years after big profit miss, disappointing outlook
Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.